Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

1.410 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,657,595
Open 1.410
Bid (Size) 2.550 (17)
Ask (Size) 2.560 (102)
Prev. Close 1.410
Today's Range 1.410 - 1.410
52wk Range 1.320 - 381.10
Shares Outstanding 11,523,716
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results
APVO shares rose 46.10% to $2.06 after promising clinical results, but the stock has dropped 98.84% over the past year. 
Via Benzinga

Performance

YTD
-98.5%
-98.5%
1 Month
-31.9%
-31.9%
3 Month
-72.5%
-72.5%
6 Month
-97.3%
-97.3%
1 Year
-99.1%
-99.1%

More News

Read More
These stocks have an unusual volume in today's session
Via Chartmill
Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort
Via Stocktwits
Discover the most active stocks in Tuesday's session.
Via Chartmill
TOMI Environmental Solutions (NASDAQ: TOMZ): The Next Era of Disinfection Technology – More Stocks Inside
Via AB Newswire
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
Via ACCESS Newswire
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
Via ACCESS Newswire
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer
Via ACCESS Newswire
Aptevo Reports 85% Remission in Q2
Via The Motley Fool
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
Via ACCESS Newswire
Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
Gapping stocks in Friday's session
Via Chartmill
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Via ACCESS Newswire
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Top movers in Thursday's after hours session
Via Chartmill

Frequently Asked Questions

Is Aptevo Therapeutics Inc. - Common Stock publicly traded?
Yes, Aptevo Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Aptevo Therapeutics Inc. - Common Stock trade on?
Aptevo Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aptevo Therapeutics Inc. - Common Stock?
The ticker symbol for Aptevo Therapeutics Inc. - Common Stock is APVO on the Nasdaq Stock Market
What is the current price of Aptevo Therapeutics Inc. - Common Stock?
The current price of Aptevo Therapeutics Inc. - Common Stock is 1.410
When was Aptevo Therapeutics Inc. - Common Stock last traded?
The last trade of Aptevo Therapeutics Inc. - Common Stock was at 09/17/25 04:00 PM ET
What is the market capitalization of Aptevo Therapeutics Inc. - Common Stock?
The market capitalization of Aptevo Therapeutics Inc. - Common Stock is 16.25M
How many shares of Aptevo Therapeutics Inc. - Common Stock are outstanding?
Aptevo Therapeutics Inc. - Common Stock has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.